retatrutide mechanism triple agonist glp-1 gip glucagon Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Retatrutide vs Tirzepatide & Semaglutide

While the mechanism is not fully understood, BPC-157 appears to influence dopamine and serotonin systems in ways that may counteract some of the mood changes that occasionally accompany significant dietary restriction

Dividing $4,200 by 36 pounds leaves us with an average annual per-pound cost of $116.67

Stock cold foods, ginger products, bland options

Katie, who is 44, had been prescribed Ozempic by her doctor two years ago, but she was ready for something new: Her co-pay had just shot up from $20 to $700 a month

Starting at the full dose can cause severe nausea, vomiting, and other gastrointestinal effects that may force you to stop again